CAccording to the journal The BMJ, this becomes more relevant in people over 60 years of age and especially in those who take statins or other drugs for cardiovascular diseases.
During five years, vitamin D was administered to 31,215 participants in the clinical trial carried out in Australia, of whom 1,336 suffered a serious cardiovascular accident, 6,6% in the placebo group and 6% in those who took the aforementioned medicine.
The rate of serious cardiovascular events was 9% lower in the vitamin D group compared to the placebo group, equivalent to 5,8 fewer events per 1,000 participants.
The source points out that the rate of myocardial infarction was 19% lower and that of coronary revascularization 11% lower in the vitamin D group, but there was no difference in the rate of stroke between the two.
Recalls the publication that cardiovascular ailments are a leading cause of death worldwide, and heart attacks and strokes are set to increase as the population continues to age and chronic diseases become more prevalent.